The cannabis industry, despite its burgeoning market size and declaration as an “essential business” during the COVID-19 pandemic, continues to grapple with fundamental access to capital. Federal prohibition in the United States creates a complex web of regulatory hurdles, severely limiting traditional banking relationships and fostering an environment where even financially sound cannabis operators face significant challenges in securing financing. This persistent gap in financial infrastructure presents a unique opportunity for specialized lenders. Adam Stettner, founder and CEO of FundCanna, a Solana Beach, California-based firm, has strategically positioned his company to address this void by applying traditional underwriting discipline and innovative financial solutions to a sector largely shunned by conventional financial institutions.
Stettner’s journey into cannabis lending was not a preordained path, but rather an emergent strategy born from observing a critical market inefficiency. His background in disciplined lending, coupled with the realization that an entire burgeoning sector lacked professional financial infrastructure, illuminated a significant opportunity. The declaration of cannabis as an essential business during the pandemic amplified this insight. While essential businesses are typically expected to have access to capital, Stettner discovered that the cannabis industry was not merely underbanked, but severely so. Traditional small businesses might see a loan approval rate of 20 to 25 percent. In stark contrast, fewer than five percent of banks were even willing to offer basic banking services, let alone credit, to cannabis operators. This profound disconnect between operational reality and financial access became the impetus for FundCanna.
The regulatory complexity, spanning state-by-state compliance frameworks, fluctuating enforcement postures, and inherent market volatility, did not deter Stettner. Instead, he recognized the underlying strength of the industry: resilient operators generating substantial revenue and demonstrating consistent demand despite these challenges. This pattern mirrored his experiences in other underbanked sectors, where strong operators were often constrained not by a lack of market demand, but by an absence of capital efficiency. Stettner’s meticulous approach involved a deep dive into the cannabis supply chain, from cultivation to retail, understanding the intricate patchwork of licensing in each state and mapping the flow of capital within the ecosystem. His objective was clear: to develop disciplined financial products that accurately reflected the industry’s operational realities. FundCanna was established with the mission to become a pragmatic, institutional-minded partner, injecting structure, rigorous underwriting, and robust financial tools into a market that had largely been left to navigate its complexities independently.
Navigating Federal Ambiguity with Institutional Rigor
The persistent federal illegality of cannabis in the United States poses a significant hurdle for traditional financial institutions, creating compliance burdens, increasing operational costs, and elevating reputational risks. FundCanna’s success in building an institutional-grade lending platform within this environment hinges on a transparent acknowledgment of these challenges and the implementation of disciplined practices where they matter most.
"You start by being honest about why banks historically steered clear," Stettner explains. "This industry sits in a federal gray area, and that creates real compliance burdens and drives up operational cost and reputational risk. From there, institutional grade means discipline where it matters."
FundCanna’s underwriting process is rooted in a granular analysis of state licensing frameworks, the specific enforcement posture of each jurisdiction, the maturity of the local market, and prevailing price dynamics. This multi-faceted approach allows for a nuanced understanding of risk beyond a simple credit score. Furthermore, the company actively diversifies its portfolio across different geographies, business verticals within the cannabis sector, and a range of operator profiles. This strategy is designed to mitigate the impact of a single regulatory shift in one location, preventing it from becoming a systemic risk to the entire portfolio.
Crucially, FundCanna’s risk management is not static. The firm employs a dynamic approach, conducting monthly reviews of its portfolio, engaging in proactive scenario planning, and making continuous adjustments to its products and credit guidelines. This contrasts with a rigid, scripture-like adherence to pre-defined rules, allowing for agility in a rapidly evolving market.
"We underwrite based on state licensing frameworks, enforcement posture, market maturity and price dynamics. We diversify across geographies, verticals and operator profiles so a regulatory shift in one place isn’t a single point of failure," Stettner elaborates. "We also keep our underwriting alive through monthly look-backs, scenario planning and product and credit adjustments, rather than treating guidelines as scripture."
A cornerstone of FundCanna’s success is its ability to design financial products that are intrinsically aligned with the natural cash flow cycles of the cannabis supply chain. Instead of attempting to force cannabis operators into the confines of standardized banking products, FundCanna tailors its offerings to meet the industry where it operates. This combination of rigorous compliance protocols, proactive credit management, and precisely fitted financial products forms the bedrock of a durable lending platform in a market that many conventional lenders continue to avoid.
The Strategic Power of Debt for Growth
For many business leaders, particularly those in founder-led or early-stage companies, the concept of incurring debt often evokes a sense of caution. This wariness is typically rooted in scenarios where revenue streams are unpredictable, or in a general consumer aversion to debt. However, Stettner advocates for a more nuanced perspective, viewing debt not as an inherent risk, but as a powerful strategic tool for growth, once a business achieves consistent cash flow and a clear understanding of its economic drivers and return on capital.
"Some CEOs, especially founders and early-stage companies, start with a natural caution toward debt. That instinct usually comes from scenarios where revenue is unpredictable or inconsistent, or the consumer mentality of buying things on debt as a negative. In those situations, wariness is rational," Stettner notes. "But once a business has established consistent cash flow, and understands their economics and path for return on capital, debt shifts from being a risk to being a strategic tool."
The critical question, according to Stettner, is not whether debt is inherently good or bad, but rather a business’s capacity to deploy capital productively and to generate returns on that capital that exceed the cost of the debt itself. When this condition is met, debt becomes a decidedly advantageous instrument.
Stettner’s philosophy emphasizes that well-utilized debt is one of the most efficient mechanisms for business expansion. He contrasts this with equity financing, which he identifies as the most expensive form of capital due to its permanent dilution of ownership. When a company can access and invest capital into activities that yield a higher return than the cost of borrowing—whether for inventory acquisition, operational expansion, managing receivables, or customer acquisition—debt enables scaling while preserving the equity value for the owners.
He draws a critical distinction between “productive debt” and “desperation debt.” Productive debt fuels profitable growth and is directly linked to revenue-generating activities or initiatives aimed at enhancing a company’s capabilities. Desperation debt, conversely, is employed to cover losses or to postpone inevitable outcomes without a clear strategy for recovery.
"The questions should center on the business’s ability to deploy capital productively and if it can ultimately earn more on the debt than the cost of the debt itself. If the answer is yes, debt is very good," Stettner states. "My philosophy is that debt, when used properly, is one of the most efficient ways to grow a business. Equity is the most expensive capital a company can use because it permanently dilutes ownership."
When debt is strategically aligned with a robust business model and healthy cash flow, it transforms from a potential burden into a potent accelerator of success. In this context, leverage is not an element to be feared, but a calculated tool to expedite achievement.
The Future of Financing in a Maturing Cannabis Landscape
As the cannabis industry continues its dynamic evolution, FundCanna remains steadfast in its commitment to building the essential financial infrastructure that has been conspicuously absent since the sector’s inception. While the industry has experienced rapid growth, the underlying systems supporting it—particularly in the realms of capital, payments, and credit—have lagged considerably. This disparity is attributable to several factors, including the relative immaturity of state-legal markets, inconsistent regulatory environments, the persistent federal prohibition, and the historical classification of cannabis alongside other “vice industries,” which has deterred broader institutional participation.
With the market’s increasing maturity, cannabis operators are increasingly seeking financing tools that mirror those available in other established industries. This includes predictable access to working capital, effective mechanisms for managing accounts receivable, and payment structures that are synchronized with actual revenue flow.
One of the most significant challenges currently observed across the cannabis supply chain is the substantial amount of capital tied up in accounts receivable. Brands and distributors frequently endure waiting periods of weeks or even months to receive payments, creating a bottleneck that impedes the entire ecosystem. To address this, FundCanna is heavily invested in developing solutions like ReadyPaid. This innovative platform enables sellers to receive immediate payment while offering buyers the flexibility of deferred payment options. By facilitating faster cash flow for both parties, ReadyPaid contributes to a more efficient and fluid market operation.
"One of the biggest problems we see today is the amount of capital trapped in accounts receivable across the supply chain. Brands and distributors are often waiting weeks or months to get paid, which slows down the entire ecosystem," Stettner highlights. "That’s why we’re focused heavily on building solutions like ReadyPaid that allow sellers to get paid immediately while giving buyers the flexibility to pay overtime. It improves cash flow for both sides and helps the market operate more efficiently."
Concurrently, FundCanna is focused on expanding its lending platform to encompass a wider array of states and industry verticals. This expansion is meticulously managed to uphold disciplined underwriting standards that remain responsive to the unique market realities of each jurisdiction.
The cannabis industry is likely to continue experiencing regulatory shifts and price compression in various regions. Therefore, the paramount objective is to develop capital solutions that are inherently flexible, transparent, and resilient. FundCanna’s overarching goal is to reduce the friction associated with financing, enabling cannabis operators to dedicate their efforts to building robust businesses within a landscape characterized by rapid change and ongoing development.
"Cannabis will continue to face regulatory shifts and price compression in certain regions, so the key is building capital solutions that are flexible, transparent and durable. Our goal is to make financing one less obstacle so operators can focus on building strong businesses in a rapidly evolving industry," Stettner concludes.
